Abacavir and lamivudine fixed-dose combination tablet once daily compared with abacavir and lamivudine twice daily in HIV-infected patients over 48 weeks (ESS30008, SEAL). (Q46798936)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Abacavir and lamivudine fixed-dose combination tablet once daily compared with abacavir and lamivudine twice daily in HIV-infected patients over 48 weeks (ESS30008, SEAL). |
scientific article |
Statements
1 reference
Abacavir and lamivudine fixed-dose combination tablet once daily compared with abacavir and lamivudine twice daily in HIV-infected patients over 48 weeks (ESS30008, SEAL). (English)
1 reference
Nestor Sosa
1 reference
Christina Hill-Zabala
1 reference
Edwin Dejesus
1 reference
Gisella Herrera
1 reference
Allison Florance
1 reference
Maria Watson
1 reference
Cindy Vavro
1 reference
Mark Shaefer
1 reference
1 December 2005
1 reference
40
1 reference
4
1 reference
422-427
1 reference
Identifiers
1 reference